An Effectiveness Trial Examining the Addition of Zinc to the Current Case Management Package of Diarrhoea in a Primary Health Care Setting. Phase I
Sponsor study identifier
Secondary identifiers
interventional
2,364
1 country
1
Study Start
August 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2004
Actual (reported)Study Completion
August 2004
Actual (reported)Use of zinc in diarrhea may be an effective intervention to reduce hospitalizations and child mortality as it could reach the most vulnerable children in a community and reduce severity of not only diarrhea but also of associated infections. It might also potentially reduce antibiotic use. We conducted a pilot study prior to conducting a community based controlled effectiveness trial to assess whether addition of zinc as a therapeutic modality for diarrhea delivered through existing channels, reduces visits to health care providers, antibiotic and other drug use, and increases ORS use during diarrhea.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2004
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2003
Date type not reportedThis date has not been verified as actual or estimated.
August 2004
Actual (reported)August 2004
Actual (reported)January 13, 2006
Actual (reported)January 18, 2006
Actual (reported)- Reduction in antibiotics and other drugs use during diarrheal illnesses
August 2003 to August 2004
- Increase in ORS use during diarrhea
August 2003 to August 2004
- Reduction in hospitalizations; all cause and diarrhea related
August 2003 to August 2004
Zinc and ORS
One strip containing 14 dispersible zinc tablets (20 mg each) along with 2 ORS packets were prescribed to all children aged 1 month to 5 years visiting that channel with diarrhea. Infants aged less than 6 months were advised half a zinc tablet in a teaspoonful of breast milk; older children were advised 1 tablet in breast milk or clean water.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Society for Applied Studies
New Delhi, National Capital Territory of Delhi, 110017, India
Bhandari N, Mazumder S, Taneja S, Dube B, Black RE, Fontaine O, Mahalanabis D, Bhan MK. A pilot test of the addition of zinc to the current case management package of diarrhea in a primary health care setting. J Pediatr Gastroenterol Nutr. 2005 Nov;41(5):685-7. doi: 10.1097/01.mpg.0000182799.69675.92.
Nita Bhandari, PhD
Society for Applied Studies
2,364 participants (actual enrollment reported by the registry).
First Submitted
January 13, 2006
First Posted
January 18, 2006
Study Start
August 2003
Date type not reportedThis date has not been verified as actual or estimated.
Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.
Contact the study team to confirm eligibility.
Primary Completion
August 2004
Actual (reported)Study Completion
August 2004
Actual (reported)Last Updated
July 2, 2008
Record last verified: 2008-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: